Novo Nordisk A/SNovo Nordisk is shortening its name to Novo and will detail its updated strategy at a Capital Markets Day on September 21, with the CEO pushing to make the company leaner.
OpenAI CEO Sam Altman confirmed the company will not go public in 2026, calling the timing "ill-advised" given current safety and alignment challenges, and has reportedly pushed advisers to target a $1 trillion valuation for any eventual offering. President Donald Trump rejected calls from tech leaders to slow AI model development, arguing restrictive guardrails would risk ceding America's technological lead to China, after proposals from Anthropic CEO Dario Amodei backed by Sam Altman and Elon Musk. Daily earnings for Very Large Crude Carriers on the benchmark Middle East-to-China route hit a record of nearly $800,000 following the biggest wave of attacks on Middle East shipping since the start of the U.S.-Iran conflict, while the U.S. Gulf-to-Asia run fetched offers at a record lump-sum fee of $29.5 million, roughly $15 per barrel before war-risk premiums. Novo Nordisk announced it will shorten its corporate name to Novo and update its logo, with CEO Mike Doustdar pushing to make the company leaner as it works to regain obesity-treatment market share against Eli Lilly, and will detail its updated strategy at a Capital Markets Day on September 21 in London.
Novo Nordisk A/SNovo Nordisk is shortening its name to Novo and will detail its updated strategy at a Capital Markets Day on September 21, with the CEO pushing to make the company leaner.
Eli Lilly and CompanyMentioned only as the rival Novo Nordisk is trying to regain obesity-treatment market share against; no new development for Lilly itself.
CEO Sam Altman confirmed OpenAI will not go public in 2026, calling the timing ill-advised given safety and alignment challenges.